Crispr Theraputics has a commercial cure for sickle cell disease, plus a promising pipeline. As soon as Crispr begins to make real money share price will fly past the moon.

Most of Wallstreet and retail investors don't understand Crispr and most see it as a very risky stock to invest in but once it begins rolling out its cures and making obscene amounts of cash..Along with license agreements to other companies Crispr Theraputics share price will rise significantly. We are very early days in Crispr story and I am looking forward to the future.

in 20 years we will look back at Crispr share price and wish we bought more 🤣